Acuitas Investments, LLC Eton Pharmaceuticals, Inc. Transaction History
Acuitas Investments, LLC
- $209 Million
- Q3 2024
A detailed history of Acuitas Investments, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 579,960 shares of ETON stock, worth $7.29 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
579,960
Previous 579,960
-0.0%
Holding current value
$7.29 Million
Previous $1.91 Million
82.34%
% of portfolio
1.66%
Previous 1.08%
Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
51Shares Held
9.44MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$34.9 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$12.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$12.6 Million0.36% of portfolio
-
Westside Investment Management, Inc.619KShares$7.78 Million0.79% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA566KShares$7.12 Million0.15% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $318M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...